Vinati Organics Limited has announced a ₹500 crore capital expenditure plan focused on developing and commercializing new specialty chemicals. These products target diverse applications including fragrances, personal care, and water treatment. The company expects these investments, funded through internal accruals, to drive significant top-line growth and contribute meaningfully to profitability. Additional capex plans are also underway, with clarity expected within six months.
Vinati Organics Expands Specialty Chemical Portfolio with ₹500 Crore Capex
Vinati Organics Limited is set to invest INR500 crores in a strategic capital expenditure plan aimed at developing and commercializing new specialty chemicals. This initiative underscores the company’s commitment to long-term growth and expansion into high-value product segments. The announcement was made during the company’s Q2 FY2027 earnings conference call on November 5, 2026.
Focus on New Product Development and Market Expansion
The planned capex will focus on specialty chemicals with applications across various industries, including fragrances, personal care, water treatment solutions, and oil fields. The company highlighted that these new products are related to its existing chemistries, leveraging established processes and adjacencies for cost leadership. Vinati Organics expressed confidence in these new ventures, stating that some products may position them as the sole or one of the few producers in India, with a significant export opportunity accounting for 65%-70% of sales. The expected ROI for these investments is in the range of 15%-20%.
Financial Performance and Future Outlook
During the Q2 FY2027 earnings call, Vinati Organics reported an increase in net income by 21% year-on-year on a standalone basis, reaching INR707 crores. However, EBITDA declined by 27% to INR142 crores. On a consolidated basis, net income rose by 23% to INR693 crores, with EBITDA declining by 24% to INR138 crores. The company anticipates ending FY2027 with a 20%-25% improvement in its top line and expects an EBITDA margin of approximately 24%-25% for the full year. The company also sees encouraging volume trends and stable performance in key segments like IBB and Butyl Phenols.
Additional Capex and Project Timelines
Beyond the initial INR500 crore capex, Vinati Organics is also planning an additional INR500 crore investment and is actively scouting for land. More clarity on this second phase is expected within the next six months as land acquisition and pilot trials progress. The company anticipates commencing commercial sales for MEHQ and related products by April 2027, with full capacity utilization expected within a year. Products from VOPL, including MEHQ, guaiacol, anisole, and others, are slated to start revenue generation from December 2026.
Addressing Market Challenges
The company acknowledged current market challenges, including increased raw material, energy, and logistics costs, partly attributed to the ongoing situation in the Middle East. While raw material price increases have been largely passed on, logistics and energy costs could not be fully absorbed, impacting the bottom line. However, the company expects improved profitability in Q3 and Q4 due to cooling logistics rates. Demand for ATBS is also projected to recover in the second half of the fiscal year.
Source: BSE
